Evidence map›Paper›PMID 35333950›Full record

ReviewMicrobial ecology2023

Trends in PHA Production by Microbially Diverse and Functionally Distinct Communities.

Vani Angra, Rutika Sehgal, Reena Gupta

Abstract readReview
PubMed Publisher
In one paragraph

Review in Microbial ecology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Vani AngraDepartment of Biotechnology, Himachal Pradesh University, Summerhill, Shimla, 171005, India.
Rutika SehgalDepartment of Biotechnology, Himachal Pradesh University, Summerhill, Shimla, 171005, India.
Reena GuptaDepartment of Biotechnology, Himachal Pradesh University, Summerhill, Shimla, 171005, India. reenagupta_2001@yahoo.com.ORCID http://orcid.org/0000-0003-0320-1660
Himachal Pradesh University · IN

Funding

Council of Scientific and Industrial Research, India 09/237(0168)/2018-EMR-I
6 · The paper itself

Abstract

Along with the wide applications of conventional plastics, they have a large number of disadvantages like their non-biodegradable nature, dependency on fossil fuels and the release of large amounts of toxic materials in the environment. Therefore, to resolve these problems, a number of bioplastics are studied, out of which polyhydroxyalkanoates are considered as the best alternatives. Polyhydroxyalkanoates (PHAs) are produced by microorganisms as intracellular granules during stressful conditions. Though a wide range of organisms can naturally produce PHAs, only a few of them can be used for commercial production. Therefore, more diverse organisms that accumulate a considerable amount of PHAs and also reduce the production cost need to be exploited. Transgenic plants, recombinant bacteria, algae and extremophiles are some diverse organisms that produce a high amount of PHAs at a low cost. So, if potential organisms are used for PHA production, bioplastics will be able to completely replace petroleum-based polymers. Therefore, our review mainly focuses on production of PHAs using potential organisms so that amount of PHAs produced is high and cost-effective which would further help in the commercialization of PHAs.

Indexed as

PetroleumPolyhydroxyalkanoatesBiopolymersPlantsPlasticsBiopolymersPetroleumPlasticsPolyhydroxyalkanoatesAlgaeExtremophilesPolyhydroxyalkanoates diversityRecombinant DNA technologyTransgenic plants

Identifiers

PMID35333950
OpenAlexW4220996706

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.